HEXA and Sandhoff disease: For this reason, our work aims at creating an enzymatic drug-delivery system based on the use of polymeric NPs made of PLA, which have been coated with the HexA enzyme in order to test them on in vitro models of the Sandhoff disease, by evaluating the restored activity of the enzyme within the cells and its ability to degrade the GM2 ganglioside.